MedTrace Logo

Comparative Study Between Nicorandil and Nifedipine for the Treatment of Preterm Labour

NCT04846621 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2021-04-15

No results posted yet for this study

Summary

Nicorandil (potassium channel activator) is claimed to be as effective as Nifedipine (calcium channel blocker) for tocolysis in preterm labour

aim of the study: To assess the efficacy of Nicorandil compared with Nifedipine as a tocolytic agent in delaying labour for 48 hours following their administration

Conditions

  • Preterm Labor With Preterm Delivery

Interventions

DRUG

Potassium Channel Opener

Randomized Controlled comparative clinical trial between two drugs as a tocolytic agent in preterm labor

DRUG

Calcium channel blocker

Randomized Controlled comparative clinical trial between two drugs as a tocolytic agent in preterm labor

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • manella beshara, master · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2021-06-30
Completion
2021-07-01

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04846621 on ClinicalTrials.gov